Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid

• Status: Unknown status
• Trial end date: 2014-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare combination atorvastatin/fenofibric acid 10/135mg with atorvastatin 20mg monotherapy in the mixed hyperlipidemia who were not at lipid goals with atorvastatin 10mg monotherapy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sang Hak Lee
• Treatments: Atorvastatin; Atorvastatin Calcium; Fenofibrate; Fenofibric acid

Criteria

Inclusion Criteria:

• patients of the age of 20years or older

• patients who have been taking atorvastatin 10mg 1 tab per day for more than 8 weeks before screening

• patients who meet the following criteria

1. Low density lipoproteins-cholesterol level < 130mg/dL

2. 150mg/dL < Triglyceride level < 500mg/dL

3. HDL-cholesterol level < 45mg/dL

• patients who consent for the consent before enrolling the study

Exclusion Criteria:

• Allergic to HMG-CoA reductase inhibitor and fibrates

• uncontrolled Hypertension

• unstable angina, myocardial infarction, transient ischemic attack

• uncontrolled diabetes

• thyroid disease

• myopathy, rhabdomyolysis history

• alcoholic

• chronic diarrhea, gastrointestinal disease

• malignant tumor

• patients who are pregnant

• lactating woman